ArticleTherapeutic advances in hematology2026
Prognostic value of patient-reported outcome thresholds on survival and adverse events in CLL/SLL: A pooled analysis of ibrutinib trials.
Ahmad Y Abuhelwa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.